The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma

Author：              

Publisher： Spandidos Publications

E-ISSN： 1791-2423|46|6|2364-2370

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.6, 2015-01, pp. : 2364-2370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma

By                          

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1674-1680

Spandidos Publications

Access to resources Recommend Favorite

Frizzled2 mediates the migration and invasion of human oral squamous cell carcinoma cells through the regulation of the signal transducer and activator of transcription-3 signaling pathway

By            

Oncology Reports, Vol. 34, Iss. 6, 2015-01 ,pp. : 3061-3067

Spandidos Publications

Access to resources Recommend Favorite

Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma

By              

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1827-1832

Spandidos Publications

Access to resources Recommend Favorite

Overexpression of fibronectin confers cell adhesionmediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells

By                          

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1376-1384

Spandidos Publications

Access to resources Recommend Favorite

Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM19

By                

Molecular Medicine Reports, Vol. 12, Iss. 6, 2015-01 ,pp. : 8185-8192

Spandidos Publications

Access to resources Recommend Favorite